ClinicalTrials.gg
RecruitingNCT06487936RELIEFUpdated Aug 23, 2024

Real-World Registry Study on Patient Satisfaction With TransLoc 3D SI Joint Fusion

An observational study in Sacroiliac Joint Dysfunction and Sacroiliac; Fusion, sponsored by CornerLoc. Recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-08-23.

Sponsored by CornerLoc · Observational

From the registry’s dates

  • Primary completion was expected by Oct 2024, 2 years ago, but the record still lists the study as recruiting.
  • Started Aug 2024; still recruiting 2 years 2 months later.
Study type
Observational
Model
Cohort
Time perspective
Other
Enrollment
120
Ages
18 Years and older
Sex
All
01

Study summary

This is a multi-center, consecutive enrollment registry study to evaluate patient satisfaction post SI Fusion with the TransLoc 3D SI Fusion System.

02

Conditions studied

  • Sacroiliac Joint Dysfunction
  • Sacroiliac; Fusion
03

In context

Lead sponsor

CornerLoc is the lead sponsor of 3 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients who have already received the TransLoc 3D System > 1 year postoperatively \< 18 months, at the time of consent.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 year or older
  • Confirmed Implant of the Transloc 3D Fusion System
  • Did not have Transloc device removed or another manufacturer device implanted post Transloc
  • Does not have other manufacturer's titanium or metal implant
  • Patient may be included with prior allograft implant
  • Willing to participate and give written consent
  • Must have or planned CT post ≥1 year per standard of care

Exclusion criteria

Exclusion Criteria:

  • Patient is younger than 18 years
  • Patient is unable to sign the
  • Implant of other manufacturer's titanium or alternative metal implant
  • Revision with another manufacturer's implant
  • Fracture or unresolved trauma of implant side after implantation of TransLoc
  • Patient unwilling to participate in Patient Satisfaction Survey
  • Patient has not returned for Standard of Care follow-up
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Other
Enrollment
120 participants (estimated)
Target follow-up
18 Months
Patient registry
Yes

Groups and cohorts

  • Implanted TransLoc 3D SIJ Fusion Patients

    Patients who were diagnosed with sacroiliitis and were treated with the TransLoc 3D System ≥ 1 year ≤ 18 months at the time of consent.

    Device: TransLoc 3D SI Joint Fusion System

Interventions

  • DeviceTransLoc 3D SI Joint Fusion System

    Satisfaction survey will be administered to collect real world evidence on patients that previously received the TransLoc 3D System commercially.

06

What researchers measure

Primary outcomes

  1. Patient Satisfaction Survey

    Patient satisfaction survey administered greater than 1 year post-op: satisfaction, functional improvement, and disability as it relates to their SI joint

    Time frame: Prospective 12 to 18 months post surgery

Secondary outcomes

  1. Visual Analogue Scale (VAS) of pain

    Retrospective analysis of VAS pre and post surgery, if available

    Time frame: Baseline up to 1 year post surgery

  2. Oswestry Disability Index (ODI)

    Retrospective analysis of ODI pre and post surgery, if available

    Time frame: Baseline up to 1 year post surgery

  3. SAEs

    Retrospective capture of Serious Adverse Events (SAEs) from the time of SI Fusion up to 90 days post operatively that required re-operation or in-patient hospitalization.

    Time frame: Time of surgery up to 90 days post surgery

  4. CT Scan Second Read (Radiological Overread)

    CT scan for placement and fusion

    Time frame: 12 to 18 months post fusion surgery

07

Study locations

1 of 1 sites recruiting
  • Advanced Orthopedic Center
    Port Charlotte, Florida 33948, United States
    Recruiting
    • Lee James, DO · Contact
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 23, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06487936
Lead sponsor
CornerLoc
Responsible party
Sponsor
First posted
Jul 5, 2024
Start date
Aug 15, 2024
Primary completion
Oct 15, 2024 (estimated)
Completion
Dec 15, 2024 (estimated)
Last update
Aug 23, 2024

Study contacts

Carley Wiegner
Contact
carley@cornerloc.com
888-743-8736
Bob Compton
Contact
bob@cornerloc.com
Lee James, DO
principal investigator · Advanced Orthopedic Center

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion